期刊文献+

筋脉通对糖尿病大鼠周围神经组织神经生长因子表达的影响 被引量:28

Effects of Jinmaitong capsule on nerve growth factor in diabetic rats
暂未订购
导出
摘要 目的:观察中药复方筋脉通对链脲佐菌素诱导的糖尿病大鼠坐骨神经神经生长因子(nerve growthfactor,NGF)mRNA和蛋白表达的影响。方法:采用链脲佐菌素一次性腹腔内注射大鼠的方法造模,简单随机分为模型对照组、筋脉通小剂量、中剂量和大剂量组、神经妥乐平组及正常对照组。成模后即开始灌胃给药,筋脉通低、中、高组分别按成人剂量的5,10,20倍给药;神经妥乐平组按成人剂量的10倍给药。模型组和正常组予灌服蒸馏水。所有实验大鼠于灌胃16周后处死。检测各组治疗前及治疗后4,8,12,16周的体重和血糖变化,并进行热水甩尾试验和机械痛阈检测,采用实时荧光定量PCR法检测坐骨神经NGF mRNA的表达,免疫组化染色法测定坐骨神经NGF蛋白的表达。结果:糖尿病大鼠血糖值均显著高于正常组(P<0.01);各治疗组血糖在各时间点与模型组相比无明显差异。造模及灌胃前后,各组大鼠之间的体重无明显差异。模型组和各治疗组较正常组甩尾潜伏期延长、机械痛阈下降,坐骨神经NGF mRNA和蛋白表达减少(P<0.05或P<0.01)。与模型组相比,筋脉通中剂量组与神经妥乐平组的甩尾潜伏期显著缩短、痛阈值显著升高,坐骨神经NGF mRNA和蛋白表达增加(P<0.05或P<0.01)。筋脉通中剂量组与神经妥乐平组相比无显著差异。结论:筋脉通能够增加糖尿病周围神经病变大鼠坐骨神经NGF mRNA的转录和蛋白的表达。 Objective: To study the effects of Jinmaitong Capsule (JMT) on the expression of NGF and NGF mRNA in STZ- induced diabetic rats. Method: Fifty SZT-induced diabetic rats were randomly divided into 5 groups including model group, low-dose JMT group (treated with JMT similar to the quintupling dose of adult recommended dosage), middle-dose JMT group ( treated with JMT similar to the decuple dose of adult recommended dosage), high-dose JMT group (treated with JMT similar to the twenty-fold dose of adult recommended dosage) and Neurotmpin group ( treated with Neuretropin similar to the decuple dose of adult recommended dosage). Ten normal rats matching with weight and age served as normal control group. All rats were given intragastric administration for 16 weeks and then killed. Body w-eight and blood glucose were detected before and at the 4, 8, 12, 16 th week after treatment. The hydrothermal tail-flick and pain threshold to mechanical stimulation with Von Frey filament were carried out before death. The expression of NGF and NGF-mRNA in sciatic nerve were detected by SABC immunohistochemical method and real-time fluorogenetic quantita- tive PCR respectively. Result: The blood glucose levels of STZ-DM rats were much higher than those of normal rats ( P 〈 0. 01 ). In all the treated groups, there were no significant differences among them compared each other or compared with model group. And it got the same result when concerning about body weight no matter how the rats were dealt with. Hydrothermal tail-flick test: The tail-flick latency of STZ-DM rats were much longer than those of normal rats (P 〈0. 01 or P 〈0. 05). Compared with model group, the time shortened significantly in low, middle-dose of JMT groups and Neutrophin group. Compared with normal group, the pain thresholds of model group decreased extremely (P 〈 0. 01 ). Compared with model group, the threshold values of low-dose, middle-dose JMT group and neutrophin group raised strikingly (P 〈 0. 05 ). The levels of NGF-mRNA expression in STZ-DM rats were much lower than those of the normal rats (P 〈 0. 01 ). Compared with model group, NGF-mRNA expression of middle-dose JMT group and Neurotrepin group upregulated noticeably (P 〈0. 01). The integrated option density of NGF expression in STZ-DM rats was much lower than the normal (P 〈0. 01 or P〈0. 05). And the levels of NGF in all the treated groups increased notably compared with model group (P 〈0. 05 or P 〈0. 01). There were no significant differences among middle-dose JMT group and Neutrephin group. Conclusion: Traditional Chinese medicine JMT could up-regulate the expression of NGF and NGF-mRNA in sciatic nerve.
出处 《中国中药杂志》 CAS CSCD 北大核心 2008年第21期2539-2544,共6页 China Journal of Chinese Materia Medica
基金 国家自然科学基金项目(30572438)
关键词 糖尿病周围神经病变 神经生长因子 热水甩尾试验 机械痛阈 实时荧光定量PCR 筋脉通 diabetic peripheral neuropathy Nerve grow factor Hydrothermal tail-flick test pain threshold to mechanical stimulation with yon frey filament real-time fluorogenetic quantitative PCR Jinmaitong capsule
  • 相关文献

参考文献13

  • 1Yasuda H, Terada M, Maeda K, et al. Diabetic neuropathy and nerve regeneration[J]. Prog Neurobiol, 2003,69(4) :229.
  • 2梁晓春,崔丽英,郭赛珊,张克俭,郝炜欣,贾力,张宏,孙仁宇,李本红,杜红.筋脉通治疗糖尿病周围神经病变的临床观察[J].中国中西医结合杂志,1999,19(9):517-519. 被引量:80
  • 3梁晓春,张宏,郭赛珊,郝伟欣,徐惠媛,贾力,张克俭,孙仁宇,贾存英.筋脉通对糖尿病大鼠坐骨神经传导速度、醛糖还原酶及山梨醇浓度的影响[J].中国糖尿病杂志,2000,8(1):37-39. 被引量:67
  • 4Vinik A I, Vinik E. Prevention of the complications of diabetes [J]. Americ J Managed Care, 2003,9(3 Suppl):S63.
  • 5Brewster W J, Fernyhough P, Lara T, et al. Diabetic neuropathy, nerve growth factor and other neurotrophic factors [ J ]. TINS, 1994,17(8) :321.
  • 6Hellweg H, Hartung H D. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: A possible role of NGF in the pathogenesis of diabetic neuropathy[ J]. J Neurosci Res, 1990,26(2) :258.
  • 7Rask C A. Biological actions of nerve growth factor in the periphend nervous system[ J]. Eur Neurol, 1999,41 ( Suppl 1 ) : 14.
  • 8宁光,邹大进,刘伟,刑惠莉,张炜,赵咏桔,鲁瑾,徐华,金杰.神经妥乐平治疗糖尿病神经病变的多中心研究[J].中华医学杂志,2004,84(21):1785-1787. 被引量:39
  • 9Ohi T, Saita K, Furukawa S, et al. Therapeutic effects of aldese reduetase inhibitor on experimental diabetic neuropathy through synthesis/secretion of nerve growth factor [ J ]. Exp Neurol, 1998,151(2) :215.
  • 10Suzuki T, Sekido H, Kato N, et al. Neurotrophin-3-induced production of nerve growth factor is suppressed in Schwann cells exposed to high glucose : involvement of the polyol pathway [ J ]. J Neurochem, 2004,91 (6) :1430.

二级参考文献24

  • 1裴瑞霞,商军科,杨国春,白小林.灯盏细辛注射液治疗早期糖尿病肾病34例[J].陕西中医,2004,25(8):678-679. 被引量:6
  • 2沈璐,李群,杨明丽,路波,胡筱娟.灯盏细辛注射液治疗糖尿病肾病70例临床观察[J].临床内科杂志,2004,21(8):570-571. 被引量:9
  • 3毛晓明.醛糖还原酶抑制剂治疗糖尿病神经病变进展[J].中华内分泌代谢杂志,1994,10(1):35-37. 被引量:20
  • 4郭军,马宏岩,王建军.菟丝子对糖尿病患者抗氧化能力的影响[J].佳木斯医学院学报,1997,20(1):39-41. 被引量:12
  • 5周云平 张家庆.醛糖还原酶(AR)的荧光光度法测定及其在糖尿病大鼠晶体AR测定中的应用[J].中华内分泌代谢杂志,1989,5(3):159-161.
  • 6沈雅舟 吴松华 等.糖尿病慢性并发症[M].上海:上海医科大学出版社,1999.265.
  • 7吴伟 翟解迪.糖尿病与自由基及抗氧化剂的临床应用[J].实用糖尿病杂志,1995,3(3):52-57.
  • 8周云平,中华内分泌代谢杂志,1989年,5卷,3期,159页
  • 9Rong R, Tang ZY, Zhao YJ, et al. The effects of actovetin on treatment of painful neuropathy of diabetes. Academic J Shanghai Second Medical University, 2001,21:71-73.荣蓉, 汤正义, 赵咏桔, 等. 爱维治治疗2型糖尿病神经病变
  • 10Shanghai multicenter clinical study group. Clinical trial for effects of methylcobalamin on the treatment of diabetic neuropathy. Chin J Endocrinol Metab, 1997,13:197-200.上海多中心临床研究协作组. 甲钴胺治疗糖尿病神经病

共引文献164

同被引文献306

引证文献28

二级引证文献186

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部